Clinical Trial Update: Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a reduced-toxicity conditioning regimen of fludarabine, cyclophosphamide, and rabbit anti-thymocyte globulin (rATG) for unrela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: The Korean Society of Pediatric Hematology Oncology | Conditions: Aplastic Anemia | Phase 2 | Status: UNKNOWN